Chris Freeman

Chris Freeman serves as officer: Chief Commercial Officer at Guardant Health, Inc. (GH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$16.92M

Net Position

Net Seller

$16.92M

Companies Traded

Active Period

Dec 2025 – Aug 2026

3 total trades

Most Recent

Sell GH

Aug 11, 2026 · $10.79M

Chris Freeman's Insider Trading at Guardant Health, Inc. (GH)

Buys

0 · $0.00

Sells

3 · $16.92M

Total Shares Bought

Total Shares Sold

119,463

GH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 11, 2026	Sell	63,605	$169.58	$10.79M	125,516
May 26, 2026	Sell	24,406	$118.67	$2.90M	60,034
Dec 8, 2025	Sell	31,452	$103.07	$3.24M	56,961

Related Insiders

Kumud Kalia

officer: Chief Information Officer

GHSell · Sep 14, 2026

AmirAli Talasaz

director, officer: Co-Chief Executive Officer

GHSell · Aug 24, 2026

Musa Tariq

Director

GHSell · Aug 18, 2026

Terilyn J. Monroe

officer: Chief People Officer

GHSell · Aug 13, 2026

Medina Manuel Hidalgo

Director

GHSell · Aug 6, 2026

CLARK IAN T

Director

GHSell · Aug 5, 2026

POTTER MYRTLE S

Director

GHSell · Jun 23, 2026

Michael Brian Bell

officer: Chief Financial Officer

GHSell · Jun 8, 2026

Explore More Insider Trading Data

GH Insider Trading Activity

View all insider trades at Guardant Health, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity